Group 1 - The core point of the news is that two companies, 聚石化学 and 豪尔赛, are under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [2][3] - 聚石化学 reported a revenue of 2.963 billion yuan for the first three quarters of 2025, a year-on-year decrease of 7.17%, and a net profit attributable to shareholders of 5.7684 million yuan, with a net loss of 24.5322 million yuan after deducting non-recurring gains and losses [2] - 豪尔赛 stated that its business operations are normal and that the investigation will not have a significant impact on its management [3] Group 2 - Next week, 38 stocks will face a total unlock market value of 21.678 billion yuan [4] - 南方航空 will have 804 million shares listed for circulation, with an unlock market value of 5.689 billion yuan [5] - 菲菱科思 will have 22 million shares listed for circulation, with an unlock market value of 1.871 billion yuan [6] Group 3 - Among the 38 stocks facing unlock, 6 stocks have a high unlock ratio exceeding 30%, including 必易微, 吉冈精密, 赛恩斯, and 菲菱科思 [8] - The average stock price of the 38 stocks has decreased by 8.22% since November, with 久其软件 showing the highest increase of 13.74% [9] - 6 stocks with reported losses in the first three quarters include 红太阳, 水发燃气, 中望软件, 生物谷, 久其软件, and 必易微, indicating higher unlock pressure [10]

Group 1 - The core point of the article is that both 聚石化学 (Jushi Chemical) and 豪尔赛 (Haosai) have received notices from the China Securities Regulatory Commission (CSRC) regarding investigations into alleged violations of information disclosure laws [2][4] - Jushi Chemical announced that it received a notice from the CSRC on November 21, 2025, indicating that the company is under investigation for suspected information disclosure violations [2] - The company stated that all its business activities are currently operating normally and it will actively cooperate with the CSRC's investigation while fulfilling its information disclosure obligations [4][6] Group 2 - Haosai also received a notice from the CSRC for suspected violations of information disclosure laws and will cooperate with the investigation [4][6] - The company confirmed that its business operations are proceeding normally and that the investigation will not have a significant impact on its management and operations [6]

Group 1: Shareholding Changes - Company Zhaoyi Innovation announced that several directors and senior management personnel plan to reduce their holdings by a total of 249,000 shares, with specific reductions from the vice chairman and general manager, as well as other vice presidents [1] - Company Super Aerospace announced a stock suspension due to its controlling shareholders planning a significant matter that may lead to a change in control [2] - Company Haosai is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [5] Group 2: Major Contracts and Projects - Company Dajin Heavy Industry's wholly-owned subsidiary signed a contract worth approximately 1.339 billion yuan for a European offshore wind farm project, which represents 35.41% of the company's audited revenue for 2024 [3] - Company Ruifeng New Materials plans to increase capital by 200 million yuan in a related party to advance a lithium hexafluorophosphate project [6] Group 3: Regulatory Actions - Company Jushi Chemical received a notice from the CSRC regarding an investigation for suspected violations of information disclosure laws [4] - Company Huosai is also under investigation by the CSRC for similar reasons [5] Group 4: Investment and Acquisitions - Company Gao Neng Environment plans to acquire 45.2% equity in three mining companies [7] - Company Aerospace Electric intends to purchase 32% equity in Shenzhen Aerospace Electric Motor System Co., Ltd. through public bidding [8]

2025.11. 21 本文字数：501，阅读时长大约1分钟 来源 | 第一财经、证券时报、公司公告 同日， 豪尔赛（002963） 公告，公司于近日收到中国证监会下发的《立案告知书》，因涉嫌信息 披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证 监会对公司进行立案。 11月21日晚， 聚石化学（688669） 公告称，公司于2025年11月21日收到中国证监会下发的《立 案告知书》，因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。 聚石化学称， 目前公司各项经营活动和业务均正常开展，将积极配合中国证监会的相关工作，并及 时履行信 息披露义务。 第 一 财 经 持 续 追 踪 财 经 热 点 。 若 您 掌 握 公 司 动 态 、 行 业 趋 势 、 金 融 事 件 等 有 价 值 的 线 索 ， 欢 迎 提 供 。 专 用 邮 箱 ： bianjibu@yicai.com （注：我们会对线索进行核实。您的隐私将严格保密。） 推荐阅读 10月新能源新车降价幅度超11% 豪尔赛表示，公司将积极配合中国证监会立案调查工作，并严格按照相关法律法规的规定和监管要求 及时履 ...

Core Viewpoint - Two listed companies, 聚石化学 and 豪尔赛, have been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [1][3]. Group 1: Company Announcements - 聚石化学 announced on November 21, 2025, that it received a notice of investigation from the CSRC due to suspected information disclosure violations [1]. - 豪尔赛 also received a notice from the CSRC for similar reasons and stated that it would cooperate with the investigation while continuing normal business operations [3]. Group 2: Financial Performance - 豪尔赛 reported a revenue of 265 million yuan for the first three quarters of the year, a decrease of 29.79% year-on-year [3]. - The company incurred a net loss of 26.31 million yuan, representing a year-on-year decrease of 523.96% [3]. - The decline in revenue was attributed to fluctuations in demand within the lighting engineering industry due to adjustments in investment rhythms in infrastructure and real estate [3]. Group 3: Corporate Governance Issues - 豪尔赛's actual controller, 戴宝林, signed a voting rights entrustment agreement with 戴聪棋, transferring all voting rights of 35.1284 million shares (23.36% of total shares) to 戴聪棋 [5]. - The company faced legal issues when 戴宝林 was prosecuted for unit bribery, leading to a fine of 7 million yuan for the company and a three-year prison sentence (with a four-year suspension) for 戴宝林 [6][7]. - The company received a warning letter from the Shenzhen Stock Exchange for failing to timely disclose information regarding these legal matters [7]. Group 4: Ongoing Legal Proceedings - On November 17, 2025, 豪尔赛 received a criminal appeal notice from the Wuhan New District People's Procuratorate, indicating that the judgment in the bribery case is subject to uncertainty due to the appeal [8].

北京商报讯(记者马换换王蔓蕾)11月21日晚间，豪尔赛（002963）披露公告称，公司于近日收到证监会 下发的《立案告知书》，因涉嫌信息披露违法违规，证监会对公司进行立案。 值得一提的是，本次遭立案前，豪尔赛曾于8月8日披露《关于公司重大事项的公告》，并于11月5日披 露《关于公司重大事项的进展公告》，对湖北省武汉市新洲区人民法院作出的刑事判决书(以下简称"判 决书")进行披露。11月16日晚间，公司再度披露公告称，公司于近日收到湖北省武汉市新洲区人民检察 院刑事抗诉书(以下简称"抗诉书")，根据抗诉书，判决书对被告单位豪尔赛、被告人戴宝林单位行贿罪 一案作出判决：被告单位豪尔赛犯单位行贿罪，判处罚金700万元；被告人戴宝林犯单位行贿罪，判处 有期徒刑三年，缓刑四年，并处罚金300万元。湖北省武汉市新洲区人民检察院依法审查后认为，该判 决对被告人适用缓刑确有错误，量刑畸轻。 豪尔赛表示，公司将积极配合证监会立案调查工作，并严格按照相关法律法规的规定和监管要求及时履 行信息披露义务。目前，公司各项经营活动正常有序开展，本次立案不会对公司经营和管理造成重大影 响。 ...

【导读】涉嫌信息披露违法违规，豪尔赛被证监会立案调查 中国基金报记者 李智 11 月 21 日， 豪尔赛 公告称， 因涉嫌信息披露违法违规，中国证监会对公司进行立案。 此 前，因涉嫌单位行贿罪，豪尔赛控股股东、实际控制人戴宝林被公安机关执行逮捕，公司因 涉嫌单位行贿罪被监察机关立案调查。 豪尔赛被立案调查 11 月 21 日，豪尔赛发布公告称，公司近日收到中国证监会下发的《立案告知书》，因涉嫌 信息披露违法违规，中国证监会对公司进行立案。 豪尔赛表示，公司将积极配合调查工作，目前各项经营活动正常有序开展，本次立案不会对 公司经营和管理造成重大影响。 因涉嫌单位行贿罪 实控人被公安机关执行逮捕 自去年 12 月份开始，豪尔赛便笼罩在负面信息的阴影之下。 2024 年 12 月 12 日，武汉市新洲区监察委员会对时任豪尔赛董事长、总经理戴宝林涉嫌违 法犯罪进行立案调查，并对其实施留置。 2025 年 4 月 22 日，武汉市新洲区监察委员会解 除对戴宝林的留置。 2025 年 6 月 19 日，武汉市公安局新洲区分局对戴宝林执行逮捕。 2025 年 8 月 7 日，豪尔赛收到湖北省武汉市新洲区人民检察院《起诉书》 ...

Group 1 - Daikin Heavy Industries' subsidiary signed a contract worth approximately 1.339 billion yuan for an offshore wind farm project in Europe, accounting for 35.41% of the company's audited revenue for 2024 [1] Group 2 - Zhaoyi Innovation announced that several board members and senior management plan to reduce their holdings by a total of 249,000 shares, due to personal financial needs, with the reduction period set from December 15, 2025, to March 14, 2026 [2] Group 3 - Jushi Chemical received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws, while the company's operations continue normally [3][6] Group 4 - Chaozhuo Aerospace announced a stock suspension due to major matters being planned by its controlling shareholders, which may lead to a change in control [4] Group 5 - Heng Rui Medicine received approval for clinical trials of SHR-1139 injection, a biopharmaceutical with no similar products approved for sale domestically or internationally, with a cumulative R&D investment of approximately 100.13 million yuan [5] Group 6 - Huayou Pharmaceutical's HYP-6589 tablet for treating advanced non-small cell lung cancer received a clinical trial application acceptance notice, with no similar products approved for sale [8] Group 7 - Renfu Pharmaceutical's application for the marketing license of Dexamethasone L-amphetamine capsules was accepted, aimed at treating ADHD, with a cumulative R&D investment of approximately 90 million yuan [10] Group 8 - Huibo Group won a bid for a 1.596 billion yuan project for the restoration of an oil field in Iraq [10]

2家上市公司，公告被证监会立案。 11月21日晚，聚石化学（688669）公告称，公司于2025年11月21日收到中国证监会下发的《立案告知书》，因公司涉嫌信息披露违法违规，中国证监会决定对 公司立案。 聚石化学称，目前公司各项经营活动和业务均正常开展，将积极配合中国证监会的相关工作，并及时履行信息披露义务。 同日，豪尔赛（002963）公告，公司于近日收到中国证监会下发的《立案告知书》，因涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和 国行政处罚法》等法律法规，中国证监会对公司进行立案。 值得注意的是，豪尔赛曾于2025年7月29日公告，公司实际控制人之一戴宝林为支持戴聪棋作为上市公司控股股东暨实际控制人行使股东权利，更好地行使公司经 营管理及重大事项决策权，与戴聪棋签署了《关于豪尔赛科技集团股份有限公司之表决权委托协议》，将持有的公司3512.84万股股份（占公司总股本的 23.36%）对应的全部表决权、召集权、提名和提案权、参会权、监督建议权以及除收益权和股份转让权等财产性权利之外的其他权利独家委托给戴聪棋行使。本 次表决权委托后，公司控股股东、实际控制人变更为戴聪棋和刘清梅；戴宝林、 ...

Core Points - Haosai has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure regulations [2][4] - The company's actual controller, Dai Baolin, has been arrested for alleged unit bribery, leading to further scrutiny of the company's operations [5][6] Group 1: Investigation Details - On November 21, Haosai announced it received a notice of investigation from the CSRC due to suspected information disclosure violations [2] - The investigation follows Dai Baolin's arrest by public security authorities for alleged unit bribery, which has raised concerns about the company's governance and internal controls [5][6] Group 2: Company Operations - Haosai stated that it will actively cooperate with the investigation and that its business operations are currently normal and orderly [4] - The company has been under negative scrutiny since December of the previous year, with regulatory bodies highlighting deficiencies in its information disclosure practices [5][6] Group 3: Regulatory Actions - The Beijing Securities Regulatory Bureau issued a warning letter to Haosai for failing to fulfill its information disclosure obligations [6][7] - The Shenzhen Stock Exchange also sent a regulatory letter to Haosai and its responsible personnel, urging strict compliance with relevant laws and regulations regarding information disclosure [8] Group 4: Company Profile - Haosai's main business includes precision stamping molds and metal structural components for new energy vehicles, fuel vehicles, energy storage equipment, and communication devices [8] - As of November 21, Haosai's stock price was reported at 16.21 yuan per share, with a total market value of 2.437 billion yuan [8]